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Scientific objective
Sjögren’s syndrome (SS) is a systemic autoimmune dis-
ease characterized by chronic focal leukocyte infiltration
and inflammation of exocrine glands including salivary
glands thereby resulting in persistent dry mouth and
consequent increased risk for dental caries and period-
ontal disease. Assessment of leukocyte infiltration into
minor salivary glands of lower lip biopsy samples is
commonly used to aid with diagnosis of SS; however,
this approach may identify 60-80% of those afflicted
with the disease thereby requiring use of additional diag-
nostic tests/markers which relies on a better understand-
ing of the pathogenesis of SS. Endoplasmic reticulum (ER)
stress response is a pivotal regulator of inflammation and
cell death. An integral component of ER stress-induced
apoptosis is expression of the growth arrest- and DNA
damage-inducible protein 153 (GADD153). Thus, we
tested the hypothesis that SS is associated with increased
salivary gland expression of GADD153 and increased leu-
kocyte infiltration thereby contributing to inflammation
and cell death.
Technical approach/methods
We utilized the non-obese diabetic (NOD) mice, a model
of SS-like disease, in association with immunostaining
and flow cytometry-based studies.
Results/interpretation
Salivary glands of NOD mice displayed a) increased
GADD153 expression, b) foci of inflammatory cell infil-
trates including CD3+ T and CD19+ B lymphocytes as
well as M1 and M2 macrophages and c) increased pro-
inflammatory interleukin (IL)-17 but reduced anti-
inflammatory cytokine, IL-10. These changes were
accompanied with disruption of mitochondrial mem-
brane potential and significant increase in apoptosis and
necrosis of salivary gland cells of NOD than control
mice. To establish the relevance of GADD153 for the
human condition, archived lower lip biopsy samples of
non-SS subjects and those with a diagnosis of SS were
subjected to immunostaining. The results show intense
GADD153 immunostaining in biopsy samples of SS com-
pared to non-SS subjects. Collectively, the results indicate
that GADD153 regulates inflammation and cell death in
salivary gland in SS.
Outlook/expert recommendations
The present study has established the relevance and signif-
icance of GADD153 as a novel predictive and prognostic
molecular fingerprint for SS. Further, assessment of minor
salivary gland GADD153 expression could potentially be a
more sensitive approach to help with diagnosis of SS, at
early stage of the disease, than leukocyte infiltration.
Importantly, subsequent studies should establish whether
inhibition of GADD153 expression ameliorates signs and
symptoms of SS for which effective treatment options
remain elusive.
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